CPC technology class · B01
B01L - Chemical Or Physical Laboratory Apparatus For General Use
Chemical or physical laboratory apparatus for general use. 15,586 US utility patents granted 2015–2025, with the leading assignees and year-by-year grant trajectory.
- 15,586
- US patents granted
- #3/5
- in B01
- 15.1%
- B01 class share
- +18%
- 5-yr velocity
The verdict
According to USPTO PatentsView, Chemical Or Physical Laboratory Apparatus For General Use ranks #121 of 670 CPC technology areas - 15,586 US patents granted since 2015, with recorded grant volume up 18% over five years.
- #121
- of 670 CPC technology areas
- 15,586
- US patents granted, 2015–2025
- International Business…
- leading assignee (242)
- +18%
- grant velocity, last 5 yrs
How B01L's grant cadence moved
Between 2020–2024, B01L recorded 7,346 grants versus 6,207 in 2015–2019 (+18% equal-window velocity). Across complete years, output peaked in 2021 at 1,487 grants and bottomed in 2015 at 1,176 (+26% peak-over-trough). Lead assignee The Regents of the University of California holds 1.5% of the class ; the top three share 4.3%.
Leaderboard read
B01L concentration, lead at 1.5%
The Regents of the University of California leads this historical grant record at 1.5% of B01L - us corporation assignees hold 66% of class grants (6,486 of 9,818). Figures describe granted US utility patents in this CPC subclass, not current investment or legal strength.
- Leader's share
- 1.5%
- Top three share
- 4.3%
- Lead over #2
- 7
239 of 15,586 grants
of the class's recorded grants
more grants than Illumina, Inc.
Where B01L sits inside B01
Among 5 subclasses in B01 (Physical OR Chemical Processes OR Apparatus IN General), B01L ranks #3 and holds 15.1% of the parent class's 103,400 recorded grants. Sibling chips below are the other subclasses in the same parent class, not the nationwide volume/lead-share peers further down.
Rising assignees active in B01L
Company-wide grant multiples (2022–2024 vs 2019–2021) among assignees with ≥5 patents in this subclass. Growth is company-wide; class patent counts are subclass-specific.
- #1 Schott Pharma Schweiz AG 33x 0 → 33 company-wide · 12 in B01L
- #2 Beijing BOE Sensor Technology Co., Ltd. 27x 3 → 81 company-wide · 10 in B01L
- #3 Eppendorf SE 19x 0 → 19 company-wide · 11 in B01L
- #4 Shaheen Innovations Holding Limted 19x 2 → 38 company-wide · 10 in B01L
- #5 Nuclera Ltd 14x 0 → 14 company-wide · 9 in B01L
B01L grants by year, peak 2021 (1,487)
US utility-patent grants per year in B01L, 2015–2025 - recent five years are up 18% versus 2015–2019.
Who leads B01L?
The 12 most active assignees in Chemical OR Physical Laboratory Apparatus FOR General USE - wider bars mean more grants
- The Regents of the…
The Regents of the University of California
239 patents
- Illumina
Illumina, Inc.
232 patents
- Becton Dickinson and
Becton, Dickinson and Company
193 patents
- Bio-rad Laboratories
Bio-Rad Laboratories, Inc.
174 patents
- President and Fellows…
President and Fellows of Harvard College
165 patents
- Life
Life Technologies Corporation
158 patents
- Roche Diagnostics…
Roche Diagnostics Operations, Inc.
141 patents
- Siemens Healthcare…
Siemens Healthcare Diagnostics Inc.
119 patents
- Gen-probe Incorporated
Gen-probe Incorporated
117 patents
- Hitachi High-tech 84
Hitachi High-tech Corporation
84 patents
- Roche Molecular… 84
Roche Molecular Systems, Inc.
84 patents
- Sysmex 82
Sysmex Corporation
82 patents
What this shows International… is the most active filer in B01L, holding 242 of the 15,586 patents in this class. Concentration at the top signals how contestable this technology area is for new entrants.
View data table
| Rank | Company | Patents in B01L |
|---|---|---|
| #1 | The Regents of the University of California | 239 |
| #2 | Illumina, Inc. | 232 |
| #3 | Becton, Dickinson and Company | 193 |
| #4 | Bio-Rad Laboratories, Inc. | 174 |
| #5 | President and Fellows of Harvard College | 165 |
| #6 | Life Technologies Corporation | 158 |
| #7 | Roche Diagnostics Operations, Inc. | 141 |
| #8 | Siemens Healthcare Diagnostics Inc. | 119 |
| #9 | Gen-probe Incorporated | 117 |
| #10 | Hitachi High-tech Corporation | 84 |
| #11 | Roche Molecular Systems, Inc. | 84 |
| #12 | Sysmex Corporation | 82 |
| #13 | The General Hospital Corporation | 81 |
| #14 | Tecan Trading AG | 71 |
| #15 | Abbott Point of Care Inc. | 70 |
| #16 | Shimadzu Corporation | 66 |
| #17 | EMD Millipore Corporation | 64 |
| #18 | Handylab, Inc. | 63 |
| #19 | Advanced Liquid Logic, Inc. | 61 |
| #20 | Hitachi High-Technologies Corporation | 59 |
Footprint here vs. claim strategy
Each dot is a leading B01L assignee, placed by how many patents it holds in this class (horizontal) against its company-wide average claims per patent (vertical) - a read on whether the class is led by broad-but-shallow filers or focused deep-claim players.
Classes near B01L's 15,586-grant footprint
Nationwide nearest neighbors for B01L (#121 of 670 by volume ; lead share 1.6%) - not the B01 parent-class siblings above.
Nearest by grant volume
Questions about B01L
Which company holds the most patents in B01L?
Which B01L assignees grew fastest recently?
How does B01L compare inside parent class B01?
What to do with this data
B01L in context - here's where to go next.
- The Regents of the University of California leads B01L with 239 grants in this class. See full portfolio
- B01L ranks #121 of 670 by grant volume among all tracked CPC technology areas. See the ranking
- Inside parent class B01, the largest sibling subclass is B01D with 43,096 grants. Explore B01D
Figures reflect USPTO PatentsView grant data through 2026-05-15; pending applications not yet granted are not counted.
Methodology - B01L figures are USPTO PatentsView granted-utility totals for this subclass (15,586 grants in the tracked window).
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.